Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbb32755ecbda278fd15cfcfd3d6f1d7 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
filingDate |
2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59a31acf9341632c85563225267fad4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f6380df0f6480a2997ac4b3692fba3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bca0223c89d18898ce0c002c1ad55e68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c10a850ac5022f9084ad9b1d4da6e4ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73f58db5b4280f0434968fdf8095e3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4a54728af32319d7373676e856bada7 |
publicationDate |
2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-103142484-B |
titleOfInvention |
Fenofibrate lipid cubic liquid crystal solid powder and preparation method thereof |
abstract |
The invention relates to the technical field of pharmaceutic preparations, and provides fenofibrate lipid cubic liquid crystal solid powder and a preparation method thereof. The fenofibrate lipid cubic liquid crystal solid powder is prepared by adding an appropriate amount of maltodextrin in fenofibrate lipid cubic crystal and spraying and drying the fenofibrate lipid cubic crystal; or adding a freeze-drying excipient in fenofibrate lipid cubic crystal and spraying and drying the fenofibrate lipid cubic crystal. The fenofibrate lipid cubic liquid crystal solid powder has the advantages of convenience in transportation and storage, high stability and high drug loading capacity and bioavailability of medicine. |
priorityDate |
2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |